The President of Guatemala said on Tuesday that the country has renegotiated its contract for the delivery of Russia's Sputnik V COVID-19 vaccines and is also in talks with Pfizer, Moderna and Johnson & Johnson for their COVID-19 shots, Reuters news agency reported on Wednesday.
Reportedly, Guatemala had a contract for the delivery of 16 million doses of Sputnik V COVID-19 vaccines but the vaccines have been delayed, prompting some officials last month to talk about asking for a refund from Russia.
Giammattei was quoted as telling a news conference that the original contract for the Russian vaccine has been renegotiated and now Guatemala would receive eight million doses.
He added that the money that was due to go towards Sputnik COVID-19 vaccines will now be reinvested to get a further eight million vaccine doses from Pfizer, Moderna or Johnson & Johnson.
According to the country' health ministry, Guatemala, with 18 million inhabitants, has so far vaccinated only 309,339 people.
GSK releases decade-long data on Shingrix efficacy
BiVictriX receives FDA Orphan Drug Designation for AML treatment candidate
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Amneal announces launch of PEMRYDI RTU, a ready-to-use oncology injectable
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
GSK's meningitis vaccine candidate accepted for FDA review
Medivir and Vetbiolix report positive results from VBX-1000 Proof-of-Concept clinical study
Norgine submits first marketing authorisation application submissions for approval of eflornithine